PACT Pharma
PACT Pharma is a biotech company in South San Francisco, United States, founded in 2017. It has raised $170.0M across 2 rounds, most recently a $75.0M Series C in March 2024.
Personalized cancer therapy through precision genome engineering
- Headquarters
- South San Francisco, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- pactpharma.com
- Total Funding
- $170.0M
- Last Round
- $75.0M Series CMar 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 5 investors for this company. The full record is or through the API.
About
PACT Pharma is a clinical-stage biopharma pioneering personalized neoantigen TCR therapies for solid tumors. PACT^NV platform uses non-viral CRISPR gene editing. Lead NeoTCR-P1.
Summary
It lists 51–200 employees. It has raised $170.0M in total across 2 rounds, most recently a $75.0M Series C round in Mar 2024. Investors include GV, Vida Ventures and AbbVie Ventures.
Funding History
Mar 2024
Sign up to see all 2 events
Funding: Series B through Series C. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pact-pharma"><img src="https://indexed.vc/api/badge/company/pact-pharma" alt="PACT Pharma on Indexed.vc" width="260" height="76" /></a>